INR 19.0
(0.42%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 134.91 Million INR | -8.44% |
2022 | 147.36 Million INR | -29.19% |
2021 | 208.11 Million INR | 16.59% |
2020 | 178.49 Million INR | 4.73% |
2019 | 170.44 Million INR | -0.19% |
2018 | 170.76 Million INR | -7.17% |
2017 | 183.95 Million INR | -13.11% |
2016 | 211.7 Million INR | 0.87% |
2015 | 209.88 Million INR | -12.71% |
2014 | 240.43 Million INR | 28.26% |
2013 | 187.46 Million INR | 95.13% |
2012 | 96.07 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 Q2 | 150.46 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 134.91 Million INR | -8.44% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 134.91 Million INR | 0.0% |
2022 FY | 147.36 Million INR | -29.19% |
2022 Q4 | 147.36 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 198.02 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2021 FY | 208.11 Million INR | 16.59% |
2021 Q1 | - INR | -100.0% |
2021 Q4 | 208.11 Million INR | 0.0% |
2021 Q2 | 165.42 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 Q1 | 161.29 Million INR | -5.37% |
2020 Q4 | 178.49 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 FY | 178.49 Million INR | 4.73% |
2020 Q2 | 161.33 Million INR | 0.03% |
2019 Q2 | 157.99 Million INR | 0.0% |
2019 FY | 170.44 Million INR | -0.19% |
2019 Q4 | 170.44 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2018 Q1 | 187.62 Million INR | 2.0% |
2018 FY | 170.76 Million INR | -7.17% |
2018 Q4 | 170.76 Million INR | 0.0% |
2018 Q3 | 170.76 Million INR | -8.99% |
2018 Q2 | 187.62 Million INR | 0.0% |
2017 FY | 183.95 Million INR | -13.11% |
2017 Q1 | - INR | 0.0% |
2017 Q2 | 183.9 Million INR | 0.0% |
2017 Q4 | 183.95 Million INR | 0.0% |
2017 Q3 | 183.95 Million INR | 0.03% |
2016 FY | 211.7 Million INR | 0.87% |
2015 FY | 209.88 Million INR | -12.71% |
2014 FY | 240.43 Million INR | 28.26% |
2013 FY | 187.46 Million INR | 95.13% |
2012 FY | 96.07 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Sigachi Industries Limited | 1.43 Billion INR | 90.569% |
Ind-Swift Limited | 10.13 Billion INR | 98.669% |
Bajaj HealthCare Limited | 3.32 Billion INR | 95.946% |
Sakar Healthcare Limited | 793.51 Million INR | 82.997% |
Aurobindo Pharma Limited | 66.47 Billion INR | 99.797% |
Innova Captab Limited | 2.45 Billion INR | 94.495% |
Divi's Laboratories Limited | 30 Million INR | -349.727% |
AstraZeneca Pharma India Limited | 45.98 Million INR | -193.415% |
Morepen Laboratories Limited | 289.99 Million INR | 53.475% |
Mankind Pharma Limited | 2.07 Billion INR | 93.488% |
Sequent Scientific Limited | 4.87 Billion INR | 97.234% |
Wanbury Limited | 1.16 Billion INR | 88.418% |
Laurus Labs Limited | 25.77 Billion INR | 99.477% |
Nectar Lifesciences Limited | 6.35 Billion INR | 97.877% |
Glenmark Life Sciences Limited | 171.48 Million INR | 21.321% |
Alembic Limited | 91.5 Million INR | -47.451% |
Hikal Limited | 8.17 Billion INR | 98.35% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 97.371% |
Neuland Laboratories Limited | 953.89 Million INR | 85.856% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 96.428% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 98.904% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 58.816% |
Themis Medicare Limited | 957.92 Million INR | 85.916% |
RPG Life Sciences Limited | - INR | -Infinity% |
Zydus Lifesciences Limited | 8.04 Billion INR | 98.322% |
Lupin Limited | 29.21 Billion INR | 99.538% |
Amrutanjan Health Care Limited | 17.28 Million INR | -680.64% |
Wockhardt Limited | 23.56 Billion INR | 99.427% |
Aarti Pharmalabs Limited | 2.85 Billion INR | 95.27% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -50.898% |
Jubilant Pharmova Limited | 36.64 Billion INR | 99.632% |
FDC Limited | 205.18 Million INR | 34.246% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 99.326% |
Kilitch Drugs (India) Limited | 316.46 Million INR | 57.367% |
Eris Lifesciences Limited | 27.81 Billion INR | 99.515% |
Venus Remedies Limited | 413.3 Million INR | 67.356% |
ZIM Laboratories Limited | 1.08 Billion INR | 87.602% |
Bliss GVS Pharma Limited | 998.4 Million INR | 86.487% |
Par Drugs and Chemicals Limited | - INR | -Infinity% |
Caplin Point Laboratories Limited | 19.7 Million INR | -584.863% |
Shilpa Medicare Limited | 9.37 Billion INR | 98.561% |
Albert David Limited | 33.24 Million INR | -305.866% |
Ajanta Pharma Limited | 352.8 Million INR | 61.758% |
Hester Biosciences Limited | 2.44 Billion INR | 94.479% |
Suven Pharmaceuticals Limited | 649.96 Million INR | 79.242% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 98.666% |
Gufic Biosciences Limited | 3.32 Billion INR | 95.947% |
Windlas Biotech Limited | 36.41 Million INR | -270.552% |
Procter & Gamble Health Limited | 95.6 Million INR | -41.128% |
Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | 56.967% |
Mangalam Drugs & Organics Limited | 984.92 Million INR | 86.302% |
Granules India Limited | 13.15 Billion INR | 98.974% |
Aarti Drugs Limited | 5.64 Billion INR | 97.609% |
Bal Pharma Limited | 1.39 Billion INR | 90.339% |
Alkem Laboratories Limited | 14.18 Billion INR | 99.049% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.588% |
Lincoln Pharmaceuticals Limited | 10.66 Million INR | -1164.698% |
Medicamen Biotech Limited | 308.17 Million INR | 56.22% |
Unichem Laboratories Limited | 2.47 Billion INR | 94.549% |
Bafna Pharmaceuticals Limited | 243.89 Million INR | 44.681% |
Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -2974.003% |
Valiant Laboratories Limited | 767.08 Million INR | 82.412% |
Orchid Pharma Limited | 1.35 Billion INR | 90.019% |
Medico Remedies Limited | 80.5 Million INR | -67.592% |
Ind-Swift Laboratories Limited | 166.21 Million INR | 18.83% |
Ipca Laboratories Limited | 14.38 Billion INR | 99.062% |
Brooks Laboratories Limited | 56.41 Million INR | -139.136% |
Syncom Formulations (India) Limited | 724.86 Million INR | 81.387% |
Piramal Enterprises Limited | 535.85 Billion INR | 99.975% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.665% |
NATCO Pharma Limited | 3.71 Billion INR | 96.365% |
Suven Life Sciences Limited | 7.09 Million INR | -1801.057% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 93.025% |
Strides Pharma Science Limited | 25.16 Billion INR | 99.464% |
Indoco Remedies Limited | 6.71 Billion INR | 97.992% |
Alpa Laboratories Limited | 52.46 Million INR | -157.158% |
Lasa Supergenerics Limited | 220.76 Million INR | 38.885% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 77.937% |